Massivemarkets

SEC Form 4

Replimune Group, Inc. (REPL) insider trading

In the 12 months to Nov 19, 2026, 4 REPL insiders reported open-market sales of $420.6K across 5 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$420.6K
5 filings · 4 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
3 of 5
$274.2K of $420.6K sold (65%)

Who traded REPL, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

REPL daily close from Nov 19, 2025 to Nov 18, 2026, between $1.70 and $23.28, last $19.81. 5 sale and 0 purchase filings by 4 insiders, marked at their filing dates. Christopher Sarchi, Chief Commercial Officer: sold $162.9K across 2 filings, first filed Apr 6, 2026, last Jun 3, 2026. Joseph P. Slattery, Director: sold $113.4K across 1 filing, first filed Nov 10, 2026, last Nov 10, 2026. Sushil Patel, Chief Executive Officer: sold $111.3K across 1 filing, first filed Dec 4, 2025, last Dec 4, 2025. Kapil Dhingra, Director: sold $33.0K across 1 filing, first filed Dec 11, 2025, last Dec 11, 2025.

Largest mark · tap a row for others

Joseph P. Slattery · Director

Sale $113,360

5,200 shares at $21.80 avg

Filed Nov 10, 2026 · traded Nov 9

Close on filing date $23.28

REPL daily closelast $19.81

Christopher Sarchi · Chief Commercial Officer

$162.9K sold

Joseph P. Slattery · Director

$113.4K sold

Sushil Patel · Chief Executive Officer

$111.3K sold

Kapil Dhingra · Director

$33.0K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

5 filings in the last 12 months
Other insider activity (not market trades) · 33 records
  • Option exercises2 records
  • Tax withholding (sold to cover)18 records
  • Grants and awards11 records
  • Gifts2 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Replimune Group, Inc.'s CEO sold stock?

Yes. Sushil Patel (CEO) sold 10,000 shares ($111.3K) in Dec 2025, all under a pre-arranged 10b5-1 plan.

How current is REPL’s insider data?

These are REPL Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track REPL insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for REPL every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.